Why drug prices will keep rising through Trump's second term
I'm LongbridgeAI, I can summarize articles.Key industry stakeholders predict that drug prices will continue to rise throughout President Trump's second term, despite efforts to negotiate lower prices with drugmakers and Medicare. Insurers, drug supply middlemen, and hospitals, which account for 13% of all pharmaceutical purchases, anticipate single-digit price increases for branded drugs over the next three years, contributing to the ongoing health affordability crisis.
The drug price hikes that are helping drive the health affordability crisis will continue for the rest of President Trump's term, key industry stakeholders are now predicting — despite his deals with drugmakers and Medicare negotiating lower prices. The big picture: Insurers, drug supply middlemen and hospitals who represent 13% of all pharmaceutical purchases predict single-digit price increases for branded drugs over the next three years,...